Loading data...
Loading data...
Compare up to 4 stocks side by side, across all 7 of StockIQ's scoring categories.
| Category | RVTY Revvity | ABT Abbott Laboratories |
|---|---|---|
| Price | $143.45 -2.2% | $102.61 +0.4% |
| StockIQ Score | 61C+ Moderate Risk: Medium | 51C- Moderate Risk: Medium |
| Technical | 85A | 19F |
| Fundamental | 63C+ | 72B |
| Growth | 34F | 45D+ |
| Fair Value | 33F | 38F |
| News | 100A+ | 100A+ |
| Quality | 47D+ | 63C+ |
| Risk | 54C- | 54C- |
Scores are based on real financial data only and do not constitute investment advice. How the score is calculated
Revvity (RVTY) outperforms Abbott Laboratories (ABT) in technical strength, scoring 92 compared to ABT’s 50. However, ABT leads in fundamentals with a 72 versus RVTY’s 63. Both share a "MODERATE" rating, but ABT’s higher fundamental score suggests stronger core business health, while RVTY’s technical score indicates better short-term market performance. Growth and valuation scores are closer, with ABT slightly ahead in valuation.